Active • Host: E. coli • AA: 32-194 • Tag: N-terminal His • MW: 21 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

FGF7 (human, recombinant)

Item No. 42756

Technical Information
Synonyms
  • Fibroblast Growth Factor 7
  • HBGF-7
  • Heparin-binding Growth Factor 7
  • Keratinocyte Growth Factor
Purity
≥95% estimated by SDS-PAGE
Endotoxin Testing
<1.0 EU/µg determined by the LAL endotoxin assay
Source
Active recombinant human N-terminal His-tagged FGF7 expressed in E. coli
Amino Acids
32-194
MW
21 kDa
Lyophilized from sterile 50 mM Tris, pH 7.5, with 250 mM sodium chloride, 5% trehalose, 5% mannitol, and 0.01% polysorbate 80
Host
E. coli
UniProt Accession №
P21781
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Fibroblast growth factor 7 (FGF7), also known as keratinocyte growth factor (KGF), is a member of the FGF7 subfamily.1,2 It is composed of an N-terminal signaling region, which is cleaved prior to secretion, a Cα backbone, a heparin-binding domain, and a receptor-binding domain.2,3 FGF7 is secreted by stromal fibroblasts and forms a quaternary complex with FGFR2b dimers, and to a lesser extent FGFR1b dimers, with heparan sulfate proteoglycans to induce ERK- or MAPK-induced proliferation in epithelial cells.4,3,1 It is also necessary for proper nephron and hippocampal development and post-radiation thymic regeneration in mice.4 Knockout of Fgf7 decreases cartilage erosion, osteophyte formation, bone density, and subchondral bone plate thickness in a mouse model of osteoarthritis induced by destabilization of the medial meniscus (DMM).5 Increased levels of FGF7 in cancer-associated fibroblasts are correlated with increased arterial and lymphatic metastasis, increased amount of residual tumor following surgery, and advanced cancer staging in patients with ovarian cancer.6 Cayman's FGF7 (human, recombinant) protein can be used for cell-based assays. This protein consists of 162 amino acids and has a calculated molecular weight of 21 kDa.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mason, I. Initiation to end point: The multiple roles of fibroblast growth factors in neural development. Nat. Rev. Neurosci. 8(8), 583-596 (2007).

    2. Ye, S., Luo, Y., Lu, W., et alStructural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry 40(48), 14429-14439 (2001).

    3. Finch, P.W., Rubin, J.S., Miki, T., et alHuman KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245(4919), 752-755 (1989).

    4. Zinkle, A., and Mohammadi, M. Structural biology of the FGF7 subfamily. Front. Genet. 10, 102 (2019).

    5. Shin, Y., Kwak, J.-S., Kim, S.K., et alFibroblast growth factor 7 (FGF7) causes cartilage destruction, subchondral bone remodeling, and the premature growth plate closure in mice. Osteoarthritis Cartilage (2024).

    6. Feng, S., Ding, B., Dai, Z., et alCancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter. J. Transl. Med. 22(1), 280 (2024).